Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fenretinide vs Placebo in CIN Grade 2-3
NCT00003075Phase 3Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Mar 1993
- Primary completion
- May 2001
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of fenretinide in cervical intraepithelial neoplasia (CIN), sponsored by University of Texas MD Anderson Cancer Center. Started Mar 1993; status: completed.
02
Drugs
fenretinide
03
Conditions
cervical intraepithelial neoplasia (CIN)
Beyond the preview
Go deeper on NCT00003075.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003075.